Why SNAP May Outshine Buffered ETFs for Advisors Seeking Flexible Risk-Managed Equity Exposure
Buffered SMAs could solve the limitations of today's buffered ETFs. Why sacrifice upside potential and creative control when you don't have to?
Buffered SMAs could solve the limitations of today's buffered ETFs. Why sacrifice upside potential and creative control when you don't have to?
Halo Investing | Oct 23, 2025 | 5 min read
Buffered ETFs often cap upside gains, underperforming in rallies like 2025's S&P surge due to their static structure. Buffered SMAs could offer superior flexibility, customization, and growth potential while managing downside risk.
Halo Investing | Oct 22, 2025 | 6 min read
NewEdge Structured Note SMA strategies could be an efficient way to tap into the potential behind Structured Notes, but without the hassle that regularly slows advisor adoption.
Halo Investing | Oct 14, 2025 | 9 min read
It's never been easier to protect your portfolio with Structured Notes. This primer offers some simple examples, including how to analyze things.
Halo Investing | Sep 18, 2025 | 6 min read
Looking for more predictable portfolio outcomes? Defined-outcome investments, like Structured Notes, can help you reshape your returns by providing downside protection in exchange for a capped upside.
Halo Investing | Aug 13, 2025 | 8 min read
Nov. 14 & 21 โข 1:00 pm CT
The information on this site (us) is intended for institutional investors and consultants to institutional investors and is published for informational purposes only. It is not intended for institutional investors in any jurisdiction in which distribution or purchase is not authorized.
Information on this site does not constitute a recommendation to purchase any product.
The information on this site (us) is intended for institutional investors and consultants to institutional investors and is published for informational purposes only. It is not intended for institutional investors in any jurisdiction in which distribution or purchase is not authorized.
Information on this site does not constitute a recommendation to purchase any product.
The information on this site (us) is intended for institutional investors and consultants to institutional investors and is published for informational purposes only. It is not intended for institutional investors in any jurisdiction in which distribution or purchase is not authorized.
Information on this site does not constitute a recommendation to purchase any product.
The information on this site (us) is intended for institutional investors and consultants to institutional investors and is published for informational purposes only. It is not intended for institutional investors in any jurisdiction in which distribution or purchase is not authorized.
Information on this site does not constitute a recommendation to purchase any product.
The information on this site (us) is intended for institutional investors and consultants to institutional investors and is published for informational purposes only. It is not intended for institutional investors in any jurisdiction in which distribution or purchase is not authorized.
Information on this site does not constitute a recommendation to purchase any product.